168 related articles for article (PubMed ID: 34533624)
21. Increased expression of TROP2 in airway basal cells potentially contributes to airway remodeling in chronic obstructive pulmonary disease.
Liu Q; Li H; Wang Q; Zhang Y; Wang W; Dou S; Xiao W
Respir Res; 2016 Nov; 17(1):159. PubMed ID: 27887617
[TBL] [Abstract][Full Text] [Related]
22. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
[TBL] [Abstract][Full Text] [Related]
23. Clinical investigation of TROP-2 as an independent biomarker and potential therapeutic target in colon cancer.
Zhao P; Yu HZ; Cai JH
Mol Med Rep; 2015 Sep; 12(3):4364-4369. PubMed ID: 26059528
[TBL] [Abstract][Full Text] [Related]
24. Tumor-associated calcium signal transducer 2 regulates neovascularization of non-small-cell lung cancer via activating ERK1/2 signaling pathway.
Guo X; Zhu X; Zhao L; Li X; Cheng D; Feng K
Tumour Biol; 2017 Mar; 39(3):1010428317694324. PubMed ID: 28345466
[TBL] [Abstract][Full Text] [Related]
25. TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.
Lin JC; Wu YY; Wu JY; Lin TC; Wu CT; Chang YL; Jou YS; Hong TM; Yang PC
EMBO Mol Med; 2012 Jun; 4(6):472-85. PubMed ID: 22419550
[TBL] [Abstract][Full Text] [Related]
26. N-glycosylation status of Trop2 impacts its surface density, interaction with claudin-7 and exosomal release.
Kamble PR; Patkar SR; Breed AA; Pathak BR
Arch Biochem Biophys; 2021 Dec; 714():109084. PubMed ID: 34774484
[TBL] [Abstract][Full Text] [Related]
27. TROP2 Expression in Sebaceous and Sweat Gland Carcinoma.
Ito T; Hashimoto H; Tanaka Y; Tanegashima K; Murata M; Ichiki T; Iwasaki T; Oda Y; Kaku-Ito Y
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160059
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway.
Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X
PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649
[TBL] [Abstract][Full Text] [Related]
29. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.
Sawanyawisuth K; Tantapotinan N; Wongkham C; Riggins GJ; Kraiklang R; Wongkham S; Puapairoj A
Ann Hepatol; 2016; 15(1):71-81. PubMed ID: 26626643
[TBL] [Abstract][Full Text] [Related]
30. Variation of Trop2 on non-small-cell lung cancer and normal cell membranes revealed by super-resolution fluorescence imaging.
Fu Y; Jing Y; Gao J; Li Z; Wang H; Cai M; Tong T
Talanta; 2020 Jan; 207():120312. PubMed ID: 31594569
[TBL] [Abstract][Full Text] [Related]
31. Can TROP2 be used as a prognostic marker in endometrioid endometrial carcinoma?
Celik SY; Çelik Öİ
Indian J Pathol Microbiol; 2020; 63(3):418-422. PubMed ID: 32769331
[TBL] [Abstract][Full Text] [Related]
32. Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus.
Hoppe S; Meder L; Gebauer F; Ullrich RT; Zander T; Hillmer AM; Buettner R; Plum P; Puppe J; Malter W; Quaas A
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230712
[TBL] [Abstract][Full Text] [Related]
33. Trop2 Expression in Extramammary Paget's Disease and Normal Skin.
Ito T; Tanegashima K; Tanaka Y; Hashimoto H; Murata M; Oda Y; Kaku-Ito Y
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299325
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Anti-Trop2 Extracellular Domain Antibodies Generated Against Peptide and Protein Immunogens for Targeting Trop2-Positive Tumour Cells.
Kamble PR; Kulkarni B; Malaviya A; Bajaj M; Breed AA; Jagtap D; Mahale S; Pathak BR
Appl Biochem Biotechnol; 2024 Jun; 196(6):3402-3419. PubMed ID: 37656352
[TBL] [Abstract][Full Text] [Related]
35. TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomas.
Ning S; Liang N; Liu B; Chen X; Pang Q; Xin T
Neurol Sci; 2013 Oct; 34(10):1745-50. PubMed ID: 23397225
[TBL] [Abstract][Full Text] [Related]
36. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362
[TBL] [Abstract][Full Text] [Related]
37. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma.
Nakashima K; Shimada H; Ochiai T; Kuboshima M; Kuroiwa N; Okazumi S; Matsubara H; Nomura F; Takiguchi M; Hiwasa T
Int J Cancer; 2004 Dec; 112(6):1029-35. PubMed ID: 15386348
[TBL] [Abstract][Full Text] [Related]
38. TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway.
Tang G; Tang Q; Jia L; Chen Y; Lin L; Kuai X; Gong A; Feng Z
Int J Mol Med; 2019 Dec; 44(6):2161-2170. PubMed ID: 31638186
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of TROP2 in human nasopharyngeal carcinoma.
Guan GF; Zhang DJ; Wen LJ; Yu DJ; Zhao Y; Zhu L; Guo YY; Zheng Y
Int J Clin Exp Pathol; 2015; 8(9):10995-1004. PubMed ID: 26617817
[TBL] [Abstract][Full Text] [Related]
40. Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments.
Omori S; Kenmotsu H; Abe M; Watanabe R; Sugino T; Kobayashi H; Nakashima K; Wakuda K; Ono A; Taira T; Naito T; Murakami H; Ohde Y; Endo M; Akiyama Y; Nakajima T; Takahashi T
Int J Clin Oncol; 2018 Dec; 23(6):1052-1059. PubMed ID: 29948239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
